{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:40:55Z","timestamp":1775173255579,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.M.I.S)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pupt.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T02:15:39Z","timestamp":1458267339000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study"],"prefix":"10.1016","volume":"37","author":[{"given":"Laura","family":"Serafino-Agrusa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Scichilone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Spatafora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2867-917X","authenticated-orcid":false,"given":"Salvatore","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2016.03.004_bib1","series-title":"Global Strategy for the Diagnosis Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2014"},{"key":"10.1016\/j.pupt.2016.03.004_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/thx.2004.021113","article-title":"NICE guidance for COPD","volume":"59","author":"Halpin","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2016.03.004_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thorax.55.2.114","article-title":"Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations","volume":"55","author":"Bhowmik","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2016.03.004_bib5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib7","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000330667","article-title":"Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease","volume":"83","author":"Bafadhel","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2016.03.004_bib9","first-page":"39","article-title":"Eosinophilic airway inflammation in COPD","volume":"1","author":"Saha","year":"2006","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"10.1016\/j.pupt.2016.03.004_bib10","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1164\/ajrccm.150.6.7952628","article-title":"Airway eosinophilia in chronic bronchitis during exacerbations","volume":"150","author":"Saetta","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2222.1996.tb00606.x","article-title":"Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis","volume":"26","author":"Saetta","year":"1996","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.pupt.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2016.03.004_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000221902","article-title":"Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD","volume":"78","author":"Bafadhel","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2016.03.004_bib16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J.\u00a0Chronic Dis."},{"key":"10.1016\/j.pupt.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1191\/0269215505cr798oa","article-title":"Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD)","volume":"19","author":"Ringbaek","year":"2005","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.pupt.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl B","key":"10.1016\/j.pupt.2016.03.004_bib23","doi-asserted-by":"crossref","first-page":"5B","DOI":"10.1155\/2007\/830570","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update","volume":"14","author":"O'Donnell","year":"2007","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.pupt.2016.03.004_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00092506","article-title":"Inflammatory changes, recovery and recurrence at COPD exacerbation","volume":"29","author":"Perera","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2016.03.004_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1183\/09031936.05.00047504","article-title":"Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease","volume":"25","author":"Fujimoto","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2016.03.004_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1378\/chest.119.3.726","article-title":"Systemic glucocorticoids in severe exacerbations of COPD","volume":"119","author":"Sayiner","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2016.03.004_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rmed.2006.07.013","article-title":"Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews","volume":"101","author":"Wood-Baker","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2016.03.004_bib28","first-page":"CD001288","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","author":"Walters","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2016.03.004_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/crj.12008","article-title":"Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials","volume":"7","author":"Cheng","year":"2013","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.pupt.2016.03.004_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalised exacerbations of COPD","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2016.03.004_bib31","article-title":"Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD","author":"Hasegawa","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2016.03.004_bib32","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.2147\/COPD.S88058","article-title":"Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?","volume":"10","author":"Salturk","year":"2015","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916300141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916300141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T03:52:22Z","timestamp":1536897142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553916300141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":32,"alternative-id":["S1094553916300141"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2016.03.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}